Powering Neurology Care
Our Story
It is a founder’s tribute to his son, lost recently to drug-resistant epilepsy, and for the millions of others who suffer from this dreadful ailment. His 20+ years of lived experience with epilepsy, combined with the team’s expertise in computational sciences and digital technologies, became the driving force behind EnlitenAI in addressing the unmet needs in seizure management.
OUR VISION
Deliver precision neurological and neurobehavioral care by transforming passive monitoring into proactive, personalized intervention – powered by a device-agnostic, context-aware AI platform.
Our platform is built to transform care for any neurological or neurobehavioral disorder characterized by episodic symptoms and highly subjective, context-dependent treatment—including epilepsy, autism spectrum disorder, PTSD, anxiety, depression, and Parkinson’s.
By capturing and translating patient-specific data into actionable insights, EnlitenAI empowers precision care where traditional approaches rely on trial-and-error. While our initial focus is seizure management in epilepsy, our vision is far greater—to deliver clarity, confidence, and measurable outcomes across the full spectrum of neurological and neurobehavioral disorders.

WE ARE DEVICE AGNOSTIC AND DATA HUNGRY!
By integrating multimodal streams from FDA-cleared wearables and implantables with real-world evidence, we enable precision drug and device titration - delivering better outcomes today, while unlocking data monetization and drug-device combination strategies for tomorrow.
Our team is extremely passionate and highly driven. Our team comprises members with extensive experience in building Digital Platforms, leveraging Data Science/AI and a great understanding of regulatory compliance and clinical development.

Dr. Himanshu Misra
Digital Health Entrepreneur with deep domain knowledge in Seizure management and Computational Sciences/AI/HPC
Dr. Paul Garcia
Professor at UCSF Neurology. Renowned Epileptologist focused on improving the diagnosis and treatment of people with hard-to-treat epilepsy.
Abhiroop Gandhi
Biopharma Business executive with extensive knowledge of risk management, global regulatory structure and clinical development.

Sreeman Nanduri
Sreeman Nanduri is a results-driven Healthcare leader with progressive experience spanning product management, technology and strategy.

Dr. Wei Fan
Dr Fan is a highly accomplished business executive and technologist with over 20yrs experience in AI, Data Analytics and Big Data R&D.
"EnlitenAI has de-risked itself with a strong regulatory strategy, clear market traction, and a scalable platform"
Mr. Jim Sergi
"EnlitenAI turns complex data into clear, actionable insights aiding treatment decisions"
Ashutosh Raina, MD
Data-driven artificial intelligence technologies have the potential to revolutionize the way seizure treatment is optimized leading to faster and better mitigation of drug-averse and common epilepsy.
Dr. Pauzaskie
"It is very helpful that EnlitenAI is developing their solution with the full ecosystem in mind, the patient/caregiver, the Neurologist, and Pharma."
Ben Walker



Our Solution
Neuroliten
Demo
Leadership
Advisors
Terms of Use
Privacy Policy
Careers
Want to Partner?